Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma Comment
Publication
, Journal Article
Zhang, T; George, DJ
Published in: CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
2020
Duke Scholars
Published In
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
ISSN
1543-0790
Publication Date
2020
Volume
18
Issue
4
Start / End Page
207 / 207
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, T., & George, D. J. (2020). Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma Comment. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 18(4), 207–207.
Zhang, Tian, and Daniel J. George. “Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma Comment.” CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY 18, no. 4 (2020): 207–207.
Zhang T, George DJ. Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma Comment. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY. 2020;18(4):207–207.
Zhang, Tian, and Daniel J. George. “Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma Comment.” CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, vol. 18, no. 4, 2020, pp. 207–207.
Zhang T, George DJ. Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma Comment. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY. 2020;18(4):207–207.
Published In
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
ISSN
1543-0790
Publication Date
2020
Volume
18
Issue
4
Start / End Page
207 / 207
Related Subject Headings
- Oncology & Carcinogenesis